Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
SYNAGEVA BIOPHARMA CORPListing unverified | Buy | $1.1M | conv 39Cluster | SEC | |
SYNAGEVA BIOPHARMA CORPListing unverified | Buy | $249.4K | conv 46ClusterFirst in 12mo | SEC |